Publication:
Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine

Simple item page
dc.contributor.authorBAŞARANOĞLU, METİN
dc.contributor.authorKapsigay, Mustafa
dc.contributor.authorKUNDUZ, ENVER
dc.contributor.institutionauthorBAŞARANOĞLU, METİN
dc.contributor.institutionauthorKUNDUZ, ENVER
dc.date.accessioned2020-06-05T20:59:51Z
dc.date.available2020-06-05T20:59:51Z
dc.date.issued2020-06-01T00:00:00Z
dc.identifier.citationBAŞARANOĞLU M., Kapsigay M., KUNDUZ E., -Increased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine-, EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.32, ss.763, 2020
dc.identifier.doi10.1097/meg.0000000000001693
dc.identifier.pubmed32355096
dc.identifier.scopus85084309923
dc.identifier.urihttps://hdl.handle.net/20.500.12645/18071
dc.identifier.wosWOS:000532197100015
dc.titleIncreased neuroendocrine tumours, but small colorectal cancer incidence in patients with inflammatory bowel disease treated by mesalazine
dc.typeArticle
dspace.entity.typePublication
local.avesis.id6fe66bc0-c089-48c4-a660-a76c98ce7364
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication8a7b20a3-6e3e-4a44-acbf-16854071f233
relation.isAuthorOfPublication7291ef45-f049-4fa7-93fd-27aa822e7bf9
relation.isAuthorOfPublication.latestForDiscovery7291ef45-f049-4fa7-93fd-27aa822e7bf9
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Yayınlar - Eserler